News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
2024-05-03 14:15:02 ET UBS analyst issues BUY recommendation for REGN on May 3, 2024 12:00PM ET. The previous analyst recommendation was Buy. REGN was trading at $947.42 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst reco...
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted EPS of $9.55, down 5% Y/Y, missing the consensus of $1...
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 15.96% on an annualized basis producing an average an...